Advertisement

Das heparininduzierte thrombozytopenisch-thrombotische Syndrom

  • R. Scherer
  • M. T. Silvanus
Conference paper
Part of the Refresher Course Aktuelles Wissen für Anästhesisten book series (REFRESHER COUR, volume 22)

Zusammenfassung

Das Symptom „Thrombozytopenie“ bei der heparininduzierten Thrombozytopenie (HIT; oder heparinassoziierte Thrombozytopenie, HAT) vom Typ II (s. unten) wird gelegentlich nicht als solches erkannt. Statt dessen besteht die Gefahr, daß lebensbedrohliche thromboembolische Komplikationen wie die Lungenembolie, der Schlaganfall oder die Extremitätenischämie als Folge unzureichender Antikoagulation gedeutet werden [16] und die Heparinzufuhr erhöht wird. Im folgenden sollen die pathophysiologischen Grundlagen der HIT sowie deren Diagnose und Therapie dargestellt werden.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    AbuRahma AF, Boland JP, Witsberger T (1991) Diagnostic and therapeutic strategies of white clot syndrome. Am J Surg 162: 175–179PubMedCrossRefGoogle Scholar
  2. 2.
    Adams JG, Humphrey LJ, Zhang X, Silver D (1995) Do patients with the heparin-induced thrombocytopenia syndrome have heparin-specific antibodies ? J Vasc Surg 21: 247–254PubMedCrossRefGoogle Scholar
  3. 3.
    Amiral J, Bridey F, Wolf M, Boyer-Neumann C et al. (1995) Antibodies to macromolecular platelet factor 4–heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb Haemostas 73: 21–28Google Scholar
  4. 4.
    Atha DH, Lormeau JC, Petitou M, Rosenberg RD, Choay J (1985) Contribution of monosaccharide residues in heparin binding to antithrombin III. Biochemistry 24: 6723–6729PubMedCrossRefGoogle Scholar
  5. 5.
    Bleasel JF, Rasko JEJ, Rickard KA, Richards G (1992) Acute adrenal insufficiency secondary to haparin-induced thrombocytopenia-thrombosis syndrome. Med J Aust 157: 192–193PubMedGoogle Scholar
  6. 6.
    Brady J, Riccio JA, Yumen OH, Makary AZ, Greenwood SM (1991) Plasmapheresis. A therapeutic option in the management of heparin-associated thrombocytopenia with thrombosis. Am J Clin Pathol 96: 394–397PubMedGoogle Scholar
  7. 7.
    Cola C, Ansell J (1989) Heparin-induced thrombocytopenia and arterial thrombosis. Alternative therapies. Am Heart J 119: 368–374CrossRefGoogle Scholar
  8. 8.
    Cole CW, Fournier LM, Bormanis J (1990) Heparin-associated thrombocytopenia and thrombosis: optimal therapy with ancrod. CJS 33: 207–210Google Scholar
  9. 9.
    Doherty D, Ortel T, DeBruijn N, Greenberg C, VanTrigt P (1995) „Heparin-free“ cardiopulmonary bypass: first reported use of heparinoid Org 10172 to provide anticoagulation for cardiopulmonary bypass.Google Scholar
  10. 10.
    Esmon CT, Esmon NL, Harris KW (1982) Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. J Biol Chem 257: 7944–7947PubMedGoogle Scholar
  11. 11.
    Greinacher A, Mueller-Eckhardt C (1991) Diagnostik der Heparin-assoziierten Thrombozytopenie. Dtsch Med Wochenschr 116: 1479–1482PubMedCrossRefGoogle Scholar
  12. 12.
    Greinacher A, Mueller-Eckhardt C (1991) Therapie der Heparin-assoziierten Thrombozytopenie. Dtsch Med Wochenschr 116: 1483–1484PubMedCrossRefGoogle Scholar
  13. 13.
    Gruel Y, Lang M, Darnige L, Pacouret G, Dreyfus X, Leroy J, Charbonnier B (1990) Fatal effect of re-exposure to heparin after previous heparin-associated thrombocytopenia and thrombosis. Lancet 336: 1077–1078PubMedCrossRefGoogle Scholar
  14. 14.
    Holmsen H (1991) Biochemistry and function of platelets. Composition of platelets. In: Williams WJ, Beutler E, Erslev AJ, Lichtman MA (eds) Hematology. McGraw Hill, New York. pp 1182–1200Google Scholar
  15. 15.
    Jaffray B, Welch GH, Cooke TG (1991) Fatal venous thrombosis after heparin therapy. Lancet 337: 561PubMedCrossRefGoogle Scholar
  16. 16.
    Kikta MJ, Keller MP, Humphrey PW, Silver D (1993) Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome? Surgery 114: 705–710PubMedGoogle Scholar
  17. 17.
    Kleinschmidt S, Seyfert, UT (1995) Heparin-associated thrombocytopenia–still a diagnostic and therapeutical problem in clinical practice. Angiology 46: 37–44PubMedCrossRefGoogle Scholar
  18. 18.
    Kleinschmidt S, Ziegenfuß T, Seyfert UT, Greinacher A (1993) Septisch-toxisches Herz-Kreislauf-Versagen als Folge einer Heparin-induzierten thrombozytopenie mit „white clot syndrome“. Anästhesiol Intensivmed Notfallmed Schmerzther 28: 58–60PubMedCrossRefGoogle Scholar
  19. 19.
    Kroll MH, Harris TS, Moake JL, Handin RI, Schafer AI (1991) Von Willebrand factor binding to platelet GPIb initiates signals for platelet activation. J Clin Invest 88: 1568–1573PubMedCrossRefGoogle Scholar
  20. 20.
    Kyritsis AP, Williams EC, Schutta HS (1990) Cerebral venous thrombosis due to heparin-induced thrombocytopenia. Stroke 21: 1503–1505PubMedCrossRefGoogle Scholar
  21. 21.
    Mahul P, Raynaud J (1995) Thrombopenie à l’héparine sous hémodialyse en reanimation: utilisation d’un heparinoide de bas poids moléculaire l’ORG 10172 ( Orgaran ). Ann Fr Anesth Reanim 14: 29–32PubMedGoogle Scholar
  22. 22.
    Marcum JA, McKenney JB, Rosenberg RD (1984) Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparin-like molecules bound to the endothelium. J Clin Invest 74: 341–345PubMedCrossRefGoogle Scholar
  23. 23.
    Marcum JA, Rosenberg RD (1987) Anticoagulantly active heparan sulfate proteoglycan and the vascular endothelium. Semin Thromb Hemost 13: 464–474PubMedCrossRefGoogle Scholar
  24. 24.
    Maurin N, Biniek R, Bohndorf K, Heintz B, Kierdorf H, Schulte.Bockholt A (1991) Heparininduzierte Thrombozytopenie and Thrombose mit spinaler Ischämie. Internist 32: 431–434PubMedGoogle Scholar
  25. 25.
    Meagher AP, Lord RSA, Graham AR, Hill DA (1991) Acute aortic occlusion presenting with lower limb paralysis. J Cardiovasc Surg 32: 643–647Google Scholar
  26. 26.
    Murray DWG, Jacques LB, Perrett TS, Best CH (1937) Heparin and the thrombosis of veins following injury. Surgery 2: 163–187Google Scholar
  27. 27.
    Niewiarowski S, Thomas DP (1969) Platelet factor 4 and adenosine diphosphate release during human platelet aggregation. Nature 222: 1269–1272PubMedCrossRefGoogle Scholar
  28. 28.
    Okajima K, Uchiba M, Murakami K (1995) Antithrombin replacement in DIC and MOF. In: Vincent JL (ed) Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York Tokio, S 457–464Google Scholar
  29. 29.
    Scheffler E, Aulmann M, Remppis A, Martin E, Fleischer F, Nawroth P (1995) Erfolgreiche Anwendung eines Heparinoids ( Danaparoid-Natrium) wegen Heparin-induzierter Thrombozytopenie Typ II bei Aortenklappenreoperation. Z Kardiol 84: 565–568PubMedGoogle Scholar
  30. 30.
    Sobel M, Adelman B (1988) Characterization of platelet binding of heparins and other glycosaminoglycans. Thromb Res 50: 815–819PubMedCrossRefGoogle Scholar
  31. 31.
    ten Cate JW, Koopman MMW, Prins MH, Büller HR (1995) Treatment of venous thromboembolism. Thromb Haemostas 74: 197–203Google Scholar
  32. 32.
    Vane JR, Änggard EE, Botting RM (1990) Regulatory functions of the vascular endothelium. N Engl J Med 323: 27–36PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • R. Scherer
  • M. T. Silvanus

There are no affiliations available

Personalised recommendations